| 12280110 |
Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
Thomas Barnett |
2025-04-22 |
| RE50230 |
Method of treatment of hypoxia inducible factor (HIF)-related conditions |
Ralph Christian Crumine |
2024-12-10 |
| 11964985 |
Anti-cancer compounds targeting Ral GTPases and methods of using the same |
Dan Theodorescu, Michael Fitzpatrick Wempe, Samy Meroueh, Martin A. Schwartz, Phillip Reigan |
2024-04-23 |
| 11756068 |
Systems and methods for providing interaction with electronic billboards |
Nanxi Liu, David Wei Zhu, Zach Spitulski, Navdeep Reddy |
2023-09-12 |
| 11472812 |
Anti-cancer compounds targeting Ral GTPases and methods of using the same |
Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan |
2022-10-18 |
| RE49129 |
Method of treatment of hypoxia inducible factor (HIF)-related conditions |
Ralph Christian Crumrine |
2022-07-12 |
| 11208471 |
Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) |
Thomas Barnett |
2021-12-28 |
| RE48557 |
Anti-cancer compounds targeting Ral GTPases and methods of using the same |
Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan |
2021-05-18 |
| 10689392 |
Anti-cancer compounds targeting ral GTPases and methods of using the same |
Dan Theodorescu, Michael Fitzpatrick Wempe, Samy Meroueh, Martin A. Schwartz, Phillip Reigan |
2020-06-23 |
| 10676480 |
Anti-cancer compounds targeting Ral GTPases and methods of using the same |
Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan |
2020-06-09 |
| 10660956 |
Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
Thomas Barnett |
2020-05-26 |
| 10570194 |
Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) |
Thomas Barnett |
2020-02-25 |
| 10214487 |
Indole derivatives and methods of using the same |
Philip Reigan, David Siegel, Christopher J. Moody, Marie A. Colucci, Donna Dehn |
2019-02-26 |
| 10202397 |
Anti-cancer compounds targeting Ral GTPases and methods of using the same |
Dan Theodorescu, Michael Fitzpatrick Wempe, Chao Yan, Phillip Reigan |
2019-02-12 |
| 9913903 |
Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
Thomas Barnett |
2018-03-13 |
| 9687530 |
Method of treatment of Hypoxia Inducible Factor (HIF)-related conditions |
Ralph Christian Crumrine |
2017-06-27 |
| 9603829 |
HSP90 inhibitors with modified toxicity |
David M. Siegal, Christopher J. Moody, Russell Richard Anthony Kitson |
2017-03-28 |
| 9353121 |
Anti-cancer compounds targeting Ral GTPases and methods of using the same |
Dan Theodorescu, Michael Fitzpatrick Wempe, Samy Meroueh, Martin A. Schwartz, Phillip Reigan |
2016-05-31 |
| 8551964 |
Hsp90 inhibitors with modified toxicity |
David Siegel, Wenchang Guo, Christopher J. Moody, Christopher S. P. McErlean |
2013-10-08 |
| 7608611 |
Hsp90 inhibitors, methods of making and uses therefor |
David Siegel, Philip Reigan, Wenchang Guo, Daniel L. Gustafson |
2009-10-27 |
| 6156744 |
DT-diaphorase directed anti-tumor agents |
John Butler, Robert H. J. Hargreaves, David Siegel, Howard D. Beall |
2000-12-05 |